In vitro models of oral squamous cell and larynx carcinoma have shown that PLGF increases expression of matrix metalloproteinases that promote pathologic neovascularization, and that PLGF inhibition slows this process [36, 37]. The gene discussed is PGF; the disease is laryngeal carcinoma.